Related Experiment Video
Updated: May 22, 2026

Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Contemporary management of pediatric venous thrombosis: how does it differ from adult care?
Alexandra Zabeida1, Hui Yin Lim2, Amy L Kiskaddon3
1Department of Pediatrics, Centre Hospitalier Universitaire Sainte-Justine - Université de Montréal, Montréal, Québec, Canada.
Insights
Pediatric venous thromboembolism (VTE) management is unique due to age-specific factors. Updated guidelines offer tailored VTE care for children, differing from adult protocols.
Area of Science:
- Hematology
- Pediatric Medicine
- Thrombosis Research
Background:
- Pediatric venous thromboembolism (VTE) management requires distinct approaches compared to adults, considering developmental hemostasis and unique clinical scenarios.
- Historically, pediatric VTE treatment relied on adult data, but recent guidelines provide evidence-based, age-specific recommendations.
- Pediatric VTE is often provoked by factors like central venous catheters or surgery, unlike the unprovoked or cancer-associated VTE common in adults.
Purpose of the Study:
- To review contemporary management strategies for pediatric venous thromboembolism (VTE).
- To highlight key differences between pediatric and adult VTE care.
- To emphasize the role of anticoagulation stewardship programs in pediatric VTE management.
Main Methods:
- Review of updated American Society of Hematology and International Society on Thrombosis and Haemostasis pediatric VTE guidelines.
- Comparison of pediatric VTE risk factors, presentation, and treatment modalities with adult VTE.
- Discussion of current anticoagulation options, including direct oral anticoagulants and parenteral agents.
- Emphasis on treatment duration and imaging-guided reassessment in pediatric VTE.
Main Results:
- Updated pediatric VTE guidelines offer tailored, evidence-based recommendations distinct from adult care.
- Direct oral anticoagulants are increasingly used in pediatrics, alongside established parenteral anticoagulants.
- Pediatric VTE management emphasizes shorter treatment courses for provoked events and imaging guidance.
- Dedicated pediatric anticoagulation stewardship programs are crucial for safety, dosing, and transitions of care.
Conclusions:
- Pediatric VTE management necessitates specialized strategies due to age-specific factors and differs significantly from adult care.
- Adherence to updated guidelines and implementation of anticoagulation stewardship programs can optimize pediatric VTE treatment.
- Shared decision-making is vital for high-quality thrombosis care across all age groups.
Abstract:
In children, venous thromboembolism is most often provoked-typically by central venous catheters or postoperative states-whereas adults more commonly present with unprovoked or cancer-associated thrombosis. While the use of direct oral anticoagulants is expanding in pediatrics with increasing safety and efficacy data, parenteral anticoagulation with low-molecular-weight heparin and unfractionated heparin remains widely used, particularly in certain clinical situations. Treatment duration also differs: pediatric guidelines support shorter courses for provoked events and emphasize imaging-guided reassessment. This JTH in Clinic article reviewed contemporary pediatric venous thromboembolism management and highlighted key differences from adult practice. The article also emphasized the importance of dedicated pediatric anticoagulation stewardship programs to improve safety, ensure optimal dosing, support transitions to oral agents, and guide treatment duration. Across all age groups, shared decision-making remains essential to delivering high-quality thrombosis care.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Pharmacokinetics in Pediatric Patients: Drug Distribution